{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:03:24Z","timestamp":1775181804534,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","interventional.theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.iccl.2016.08.004","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T07:01:45Z","timestamp":1479884505000},"page":"49-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ticagrelor"],"prefix":"10.1016","volume":"6","author":[{"given":"Wael","family":"Sumaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Storey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.iccl.2016.08.004_bib1","first-page":"353","article-title":"Protease-activated receptors and platelet function","volume":"82","author":"Coughlin","year":"1999","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.iccl.2016.08.004_bib2","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2174\/138161206776361318","article-title":"Biology and pharmacology of the platelet P2Y12 receptor","volume":"12","author":"Storey","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"10","key":"10.1016\/j.iccl.2016.08.004_bib3","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/CIRCULATIONAHA.105.574830","article-title":"Protease-activated receptors in cardiovascular diseases","volume":"114","author":"Leger","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.iccl.2016.08.004_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.iccl.2016.08.004_bib5","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.iccl.2016.08.004_bib6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.iccl.2016.08.004_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.iccl.2016.08.004_bib8","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.iccl.2016.08.004_bib9","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.jacc.2012.07.021","article-title":"Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery","volume":"60","author":"Varenhorst","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.iccl.2016.08.004_bib10","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1136\/heartjnl-2014-305619","article-title":"Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes","volume":"100","author":"Varenhorst","year":"2014","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.iccl.2016.08.004_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/09537104.2013.842965","article-title":"Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study","volume":"25","author":"Storey","year":"2014","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.iccl.2016.08.004_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1160\/TH14-12-1067","article-title":"The role of platelets in inflammation","volume":"114","author":"Thomas","year":"2015","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.iccl.2016.08.004_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","article-title":"Platelet\u00a0alpha-granules: basic biology and clinical correlates","volume":"23","author":"Blair","year":"2009","journal-title":"Blood Rev"},{"issue":"11","key":"10.1016\/j.iccl.2016.08.004_bib14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2169\/internalmedicine.40.1085","article-title":"Activated platelets and endothelial cell interaction with neutrophils under flow conditions","volume":"40","author":"Mine","year":"2001","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.iccl.2016.08.004_bib15","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1182\/blood.V93.3.876","article-title":"Platelet\/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b\/CD18 adhesion: role of PSGL-1 as a signaling molecule","volume":"93","author":"Evangelista","year":"1999","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1016\/j.iccl.2016.08.004_bib16","first-page":"25","article-title":"Pharmacokinetics of clopidogrel","volume":"25","author":"Caplain","year":"1999","journal-title":"Semin Thromb Hemost"},{"issue":"9892","key":"10.1016\/j.iccl.2016.08.004_bib17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.iccl.2016.08.004_bib18","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/01.ATV.0000225288.74170.dc","article-title":"Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects","volume":"26","author":"Heitzer","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.iccl.2016.08.004_bib19","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2003.10.071","article-title":"Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome","volume":"43","author":"Xiao","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.iccl.2016.08.004_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00029330-200601010-00006","article-title":"Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome","volume":"119","author":"Chen","year":"2006","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1016\/j.iccl.2016.08.004_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.amjcard.2004.04.035","article-title":"Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention","volume":"94","author":"Vivekananthan","year":"2004","journal-title":"Am J Cardiol"},{"issue":"25","key":"10.1016\/j.iccl.2016.08.004_bib22","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.iccl.2016.08.004_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1160\/TH15-12-0944","article-title":"P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction. The PRIVATE-ATLANTIC study","volume":"116","author":"Silvain","year":"2016","journal-title":"Thromb Haemost"},{"issue":"18","key":"10.1016\/j.iccl.2016.08.004_bib24","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jacc.2010.03.100","article-title":"Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient outcomes) PLATELET substudy","volume":"56","author":"Storey","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.iccl.2016.08.004_bib25","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1161\/ATVBAHA.115.306528","article-title":"Platelet P2Y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model","volume":"35","author":"Thomas","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.iccl.2016.08.004_bib26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev.pharmtox.41.1.775","article-title":"Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection","volume":"41","author":"Linden","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.iccl.2016.08.004_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2174\/157016109789043892","article-title":"Nucleoside transporter proteins","volume":"7","author":"Molina-Arcas","year":"2009","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"10.1016\/j.iccl.2016.08.004_bib28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jcp.1041280319","article-title":"Transport and metabolism of adenosine in human erythrocytes: effect of transport inhibitors and regulation by phosphate","volume":"128","author":"Plagemann","year":"1986","journal-title":"J\u00a0Cell Physiol"},{"issue":"1","key":"10.1016\/j.iccl.2016.08.004_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2013.06.002","article-title":"Cardiovascular adenosine receptors: expression, actions and interactions","volume":"140","author":"Headrick","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.iccl.2016.08.004_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fendo.2012.00113","article-title":"An emerging role for adenosine and its receptors in bone homeostasis","volume":"3","author":"Ham","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"193","key":"10.1016\/j.iccl.2016.08.004_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-3-540-89615-9_6","article-title":"Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology","author":"Mustafa","year":"2009","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"10.1016\/j.iccl.2016.08.004_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jcp.22379","article-title":"Physiological implications of adenosine receptor-mediated platelet aggregation","volume":"226","author":"Johnston-Cox","year":"2011","journal-title":"J\u00a0Cell Physiol"},{"issue":"4","key":"10.1016\/j.iccl.2016.08.004_bib33","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/ATVBAHA.111.226845","article-title":"Regulation of neutrophil function by adenosine","volume":"32","author":"Barletta","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.iccl.2016.08.004_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1096\/fasebj.9.5.7896004","article-title":"Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes","volume":"9","author":"Belardinelli","year":"1995","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.iccl.2016.08.004_bib35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pupt.2010.02.002","article-title":"Blockade of airway sensory nerves and dyspnea in humans","volume":"23","author":"Burki","year":"2010","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.iccl.2016.08.004_bib36","doi-asserted-by":"crossref","first-page":"F382","DOI":"10.1152\/ajprenal.00581.2012","article-title":"Tubuloglomerular feedback and renal function in mice with targeted deletion of the type 1 equilibrative nucleoside transporter","volume":"304","author":"Li","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.iccl.2016.08.004_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1074248411410883","article-title":"Ticagrelor inhibits adenosine uptake in\u00a0vitro and enhances adenosine-mediated hyperemia responses in a canine model","volume":"17","author":"van Giezen","year":"2012","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.iccl.2016.08.004_bib38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jacc.2012.11.032","article-title":"Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans","volume":"61","author":"Wittfeldt","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.iccl.2016.08.004_bib39","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jacc.2013.09.067","article-title":"Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome","volume":"63","author":"Bonello","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.iccl.2016.08.004_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1074248413511693","article-title":"Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1","volume":"19","author":"Armstrong","year":"2014","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.iccl.2016.08.004_bib41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCINTERVENTIONS.113.000293","article-title":"Differential effect of ticagrelor versus prasugrel on coronary blood flow velocity in patients with non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: an exploratory study","volume":"6","author":"Alexopoulos","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.iccl.2016.08.004_bib42","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/jth.12360","article-title":"Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism","volume":"11","author":"Nylander","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"issue":"10","key":"10.1016\/j.iccl.2016.08.004_bib43","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jacc.2015.12.062","article-title":"Platelet inhibition with Ticagrelor 60 mg versus 90 mg twice daily in the PEGASUS-TIMI 54 trial","volume":"67","author":"Storey","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.iccl.2016.08.004_bib44","doi-asserted-by":"crossref","first-page":"8260","DOI":"10.4049\/jimmunol.175.12.8260","article-title":"Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism","volume":"175","author":"Nemeth","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"19","key":"10.1016\/j.iccl.2016.08.004_bib45","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2007.07.053","volume":"50","author":"Cannon","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.iccl.2016.08.004_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2010.01.062","article-title":"Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET\/OFFSET study","volume":"56","author":"Storey","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.iccl.2016.08.004_bib47","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1093\/eurheartj\/ehr231","article-title":"Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes","volume":"32","author":"Storey","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2016.08.004_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijcard.2015.08.162","article-title":"Dyspnea related to reversibly-binding P2Y12 inhibitors: a review of the pathophysiology, clinical presentation and diagnostics","volume":"202","author":"Unverdorben","year":"2016","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2016.08.004_bib49","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/2048872614554108","article-title":"Dyspnoea management in acute coronary syndrome patients treated with ticagrelor","volume":"4","author":"Parodi","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"1","key":"10.1016\/j.iccl.2016.08.004_bib50","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pupt.2007.02.004","article-title":"Effects of airway anesthesia on dyspnea and ventilatory response to intravenous injection of adenosine in healthy human subjects","volume":"21","author":"Burki","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.iccl.2016.08.004_bib51","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1160\/TH12-08-0547","article-title":"Why does ticagrelor induce dyspnea?","volume":"108","author":"Cattaneo","year":"2012","journal-title":"Thromb Haemost"},{"issue":"19","key":"10.1016\/j.iccl.2016.08.004_bib52","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2010.11.056","volume":"57","author":"Scirica","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.iccl.2016.08.004_bib53","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000347122","article-title":"Ticagrelor improves peripheral arterial function in patients with a previous acute coronary syndrome","volume":"124","author":"Torngren","year":"2013","journal-title":"Cardiology"},{"issue":"4","key":"10.1016\/j.iccl.2016.08.004_bib54","doi-asserted-by":"crossref","first-page":"H1633","DOI":"10.1152\/ajpheart.00575.2004","article-title":"Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease","volume":"288","author":"Sato","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.iccl.2016.08.004_bib55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.thromres.2011.12.029","article-title":"Ticagrelor, but not clopidogrel and prasugrel, prevents ADP-induced vascular smooth muscle cell contraction: a placebo-controlled study in rats","volume":"130","author":"Grzesk","year":"2012","journal-title":"Thromb Res"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745816300876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745816300876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T16:07:29Z","timestamp":1657814849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745816300876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S2211745816300876"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2016.08.004","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ticagrelor","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2016.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}